CSIMarket
 


Skinvisible Inc   (SKVI)
Other Ticker:  
 
 

SKVI's Free Cash Flow Growth by Quarter and Year

Skinvisible Inc 's Free Cash Flow results by quarter and year




SKVI Free Cash Flow (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter December - 0.04 0.02 0.05
III Quarter September 0.00 -0.04 -0.02 -0.02
II Quarter June -0.02 0.15 0.03 -0.09
I Quarter March -0.05 0.22 -0.02 0.01
FY   -0.07 0.37 0.01 -0.05



SKVI Free Cash Flow third quarter 2023 Y/Y Growth Comment
Skinvisible Inc in the third quarter 2023 recorded free cash outflow of $ 0.00 millions.

Looking into third quarter 2023 results within Major Pharmaceutical Preparations industry 27 other companies have achieved higher Free Cash Flow growth. While Skinvisible Inc ' s Free Cash Flow no change of % ranks overall at the positon no. 1380 in the third quarter 2023.




SKVI Free Cash Flow ( Y/Y Growth %) 2023
2022 2021 2020
IV Quarter December - 100 % -60 % -
III Quarter September - - - -
II Quarter June - 400 % - -
I Quarter March - - - -50 %
FY   - 3600 % - -

Financial Statements
Skinvisible Inc 's third quarter 2023 Free Cash Flow $ 0.00 millions SKVI's Income Statement
Skinvisible Inc 's third quarter 2022 Free Cash Flow $ -0.04 millions Quarterly SKVI's Income Statement
New: More SKVI's historic Free Cash Flow Growth >>


SKVI Free Cash Flow (Quarter on Quarter Growth %)

2023
2022 2021 2020
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - -31.82 % - -
I Quarter March - 1000 % - -
FY (Year on Year)   - 3600 % - -




Free Cash Flow third quarter 2023 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #28
Healthcare Sector #106
Overall #1380

Free Cash Flow Y/Y Growth Statistics
High Average Low
3927.58 % 478.12 % -375.31 %
(Jun 30 2022)   (Mar 31 2019)
Free Cash Flow third quarter 2023 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #28
Healthcare Sector #106
Overall #1380
Free Cash Flow Y/Y Growth Statistics
High Average Low
3927.58 % 478.12 % -375.31 %
(Jun 30 2022)   (Mar 31 2019)

Free Cash Flow by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Skinvisible Inc 's Q/Q Free Cash Flow Growth


Free Cash Flow Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


SKVI's III. Quarter Q/Q Free Cash Flow Comment
Although Skinvisible Inc in the III. Quarter 2023 revealed free cash outflow of $ 0.00 millions, some analyst mentioned, that current results are slight up side compare to the -0.02 millions in the second quarter.

Within Major Pharmaceutical Preparations industry Skinvisible Inc achieved highest sequential Free Cash Flow growth. While Skinvisible Inc 's Free Cash Flow growth quarter on quarter, overall rank is .


Free Cash Flow Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Free Cash Flow Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Free Cash Flow Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


SKVI's III. Quarter Q/Q Free Cash Flow Comment
Despite the fact, that Skinvisible Inc in the III. Quarter 2023 showed free cash outflow of $ 0.00 millions, management point out, that this point to improvement compare to the -0.02 millions in the second quarter.

Within Major Pharmaceutical Preparations industry Skinvisible Inc achieved highest sequential Free Cash Flow growth. While Skinvisible Inc 's Free Cash Flow growth quarter on quarter, overall rank is .


Skinvisible Inc 's 12 Months Free Cash Flow Growth Year on Year


Free Cash Flow TTM Growth

12 Months Ending
(Sep 30 2023)
12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Jun 30 2022)
12 Months Ending
(Mar 31 2022)
Cumulative Free Cash Flow 12 Months Ending $ -0.03 $ -0.07 $ 0.10 $ 0.37 $ 0.35
Y / Y Free Cash Flow Growth (TTM) - - -59.32 % 3927.58 % 660.22 %
Year on Year Free Cash Flow Growth Overall Ranking # 63 # 49 # 76 # 13 # 69
Seqeuential Free Cash Flow Change (TTM) - - -72.74 % 7.24 % -6.75 %
Seq. Free Cash Flow Growth (TTM) Overall Ranking # 1380 # 551 # 26 # 932 # 1545




Cumulative Free Cash Flow growth Comment
Skinvisible Inc realized trailing twelve months free cash outflow of $ 0 millions, in the Sep 30 2023, compare to Free Cash Flow of $ 0 millions a year ago.

Among companies within the Healthcare sector 6 other companies have achieved higher trailing twelve month Free Cash Flow growth. While Free Cash Flow growth total ranking has deteriorated compare to previous quarter from 49 to 63.

Free Cash Flow TTM Q/Q Growth Statistics
High Average Low
3927.58 %
478.12 %
-375.31 %
 

Free Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 28
Healthcare Sector # 7
Overall # 63

Free Cash Flow TTM Y/Y Growth Statistics
High Average Low
3927.58 %
478.12 %
-375.31 %
 


Free Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry # 28
Sector # 106
S&P 500 # 1380
Cumulative Free Cash Flow growth Comment
Skinvisible Inc realized trailing twelve months free cash outflow of $ 0 millions, in the Sep 30 2023, compare to Free Cash Flow of $ 0 millions a year ago.

Among companies within the Healthcare sector 6 other companies have achieved higher trailing twelve month Free Cash Flow growth. While Free Cash Flow growth total ranking has deteriorated compare to previous quarter from 49 to 63.

Free Cash Flow TTM Q/Q Growth Statistics
High Average Low
3927.58 %
478.12 %
-375.31 %
 


Free Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 28
Healthcare Sector # 7
Overall # 63

Free Cash Flow TTM Y/Y Growth Statistics
High Average Low
3927.58 %
478.12 %
-375.31 %
 


Free Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry # 28
Sector # 106
S&P 500 # 1380




Other Free Cash Flow Growth
Major Pharmaceutical Preparations Industry Free Cash Flow Growth Trends and Statistics
Healthcare Sector Free Cash Flow Growth Statistics
Free Cash Flow Growth Trends for overall market
SKVI's Free Cash Flow Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Free Cash Flow Growth
Lowest Ranking Free Cash Flow Growth
Free Cash Flow Growth for SKVI's Competitors
Free Cash Flow Growth for Skinvisible Inc 's Suppliers
Free Cash Flow Growth for SKVI's Customers

You may also want to know
SKVI's Annual Growth Rates SKVI's Profitability Ratios SKVI's Asset Turnover Ratio SKVI's Dividend Growth
SKVI's Roe SKVI's Valuation Ratios SKVI's Financial Strength Ratios SKVI's Dividend Payout Ratio
SKVI's Roa SKVI's Inventory Turnover Ratio SKVI's Growth Rates SKVI's Dividend Comparisons



Companies with similar Free Cash Flow no change for the quarter ending Sep 30 2023 within Healthcare SectorY/Y Change %Free Cash Flow for the quarter ending Sep 30 2023
Abbvie inc -0.37%$ -0.368 millions
Insulet Corporation-1.23%$ -1.235 millions
National Research Corporation-2.32%$ -2.318 millions
Fonar Corporation-2.93%$ -2.929 millions
Viatris Inc -4.02%$ -4.016 millions
Pediatrix Medical Group Inc -4.07%$ -4.071 millions
Repligen Corp-5.16%$ -5.164 millions
Davita Inc -6.95%$ -6.948 millions
Amgen Inc -7.32%$ -7.320 millions
Adapthealth Corp -7.65%$ -7.653 millions
Dexcom Inc -8.19%$ -8.186 millions
Biogen Inc -10.38%$ -10.378 millions
Avantor Inc -10.69%$ -10.685 millions
Amneal Pharmaceuticals Inc -13.02%$ -13.020 millions
Biomarin Pharmaceutical Inc-14.32%$ -14.322 millions
Organon and Co -17.67%$ -17.666 millions
Hca Healthcare Inc -17.91%$ -17.914 millions
Zimmer Biomet Holdings Inc -25.11%$ -25.111 millions
International Stem Cell Corporation-26.19%$ -26.190 millions
Jazz Pharmaceuticals Plc-26.51%$ -26.507 millions
Universal Health Services Inc -26.74%$ -26.740 millions
Brookdale Senior Living Inc -27.96%$ -27.956 millions
Pacific Health Care Organization Inc -29.00%$ -29.004 millions
Option Care Health Inc -29.95%$ -29.952 millions
Iqvia Holdings Inc -32.44%$ -32.445 millions
Abbott Laboratories-32.48%$ -32.482 millions
Bruker Corporation-36.55%$ -36.547 millions
Sotera Health Company-38.26%$ -38.257 millions
Puma Biotechnology Inc -38.50%$ -38.496 millions
Luna Innovations Inc-38.51%$ -38.514 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com